adults said theyve taken a GLP-1 drug, used to treat type 2 diabetes and obesity, according to a Kaiser Family Foundation poll published in May 2024
Neither synthetic peptide is approved for tanning by health authorities
However, ongoing safety monitoring on Hers depends on patient-initiated check-ins rather than mandatory follow-up labs or clinical assessments, which may delay detection of dose-related complications or emerging health concerns
Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin
Rapid weight loss , a desired therapeutic effect of GLP-1 therapy, may theoretically contribute
The committee voted against adding to the list one of the peptides being considered, emideltide